Professor of Pediatrics, University of Minnesota

Joined December 2009
4 Photos and videos
At the Brain Cancer Symposium in Canada, sharing data from OX2 Therapeutics. Thank you ⁦@DIPGCollab
4
New news from the University of Minnesota Brain Tumor Program share.google/kVGMuMwNLinCJID…

2
I'm excited to be part of this upcoming live discussion on MEK Inhibitors in Neurofibromatosis Type 1 presented by @cec_onc! Tune in online on 5/8 at 12:15p ET & earn 1.0 free #CME/CE credit ➡️ ce.ceconcepts.com/MMS-153 #MedX #MedEd
1
3
951
I hope that these data will help to bring mirdametinib to people living with neurofibromatosis, type 1. Thank you to SpringWorks Therapeutics, my co-authors, and the patients and families who contributed their time and effort to making this clinical trial successful.
1
68
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma | Journal of Clinical Oncology ascopubs.org/doi/pdf/10.1200… I am honored to be lead author on this publication.

53
#dipgcollaborative Matt Dun innovative researcher of the year
21
#dipgcollaborative in Lexington, Kentucky. Great folks, great science!
25